NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 430 filers reported holding NOVAVAX INC in Q4 2021. The put-call ratio across all filers is 1.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $333,829 | +4.1% | 46,109 | +6.8% | 0.00% | – |
| Q2 2023 | $320,805 | +36.4% | 43,177 | +27.2% | 0.00% | – |
| Q1 2023 | $235,197 | -13.9% | 33,939 | +27.7% | 0.00% | – |
| Q4 2022 | $273,212 | -52.7% | 26,577 | -16.3% | 0.00% | -100.0% |
| Q3 2022 | $578,000 | -64.6% | 31,768 | +0.1% | 0.00% | -50.0% |
| Q2 2022 | $1,632,000 | -30.3% | 31,723 | -0.3% | 0.00% | 0.0% |
| Q1 2022 | $2,343,000 | -57.8% | 31,808 | -18.1% | 0.00% | -60.0% |
| Q4 2021 | $5,555,000 | -12.9% | 38,829 | +26.1% | 0.01% | -16.7% |
| Q3 2021 | $6,381,000 | +15.9% | 30,781 | +18.7% | 0.01% | 0.0% |
| Q2 2021 | $5,504,000 | +42.1% | 25,923 | +21.4% | 0.01% | +50.0% |
| Q1 2021 | $3,873,000 | +13.3% | 21,361 | -30.3% | 0.00% | 0.0% |
| Q4 2020 | $3,418,000 | +39.3% | 30,656 | +35.4% | 0.00% | 0.0% |
| Q3 2020 | $2,453,000 | +95.0% | 22,639 | +50.0% | 0.00% | +100.0% |
| Q2 2020 | $1,258,000 | -3.2% | 15,090 | -84.2% | 0.00% | -33.3% |
| Q1 2020 | $1,300,000 | – | 95,733 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |